December 2016

Consumer Drug Safety
Defective Drugs

Recent FDA Action May Increase the Number of Invokana Injuries

Just three years after its approval, the Type 2 diabetes medication, Invokana (canagliflozin), multiple warnings and safety alerts have already… Read More